Dogwood Therapeutics, Inc. (DWTX)
4.08
-0.08
(-1.92%)
USD |
NASDAQ |
Jan 02, 12:12
Dogwood Therapeutics EPS Diluted (Quarterly): -8.203 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bicara Therapeutics, Inc. | -0.6658 |
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.74M |
| Total Expenses (Quarterly) | 15.74M |
| Enterprise Value | 110.05M |
| Earnings Yield | -611.1% |
| Normalized Earnings Yield | -538.14 |